Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer

Genomics

Volumn 81, Issue 2, 2003, Pages 105-107

  Han, Shuang Yin ^a   Druck, Teresa ^a   Huebner, Kay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Amplification; CAV1; CAV2; Common fragile site; FRA7G; TESTIN; Tumor suppressor gene

Indexed keywords

ONCOPROTEIN; PROTEIN CAV1; PROTEIN CAV2; PROTEIN TESTIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC CODE; GENOMICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOMATIC MUTATION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0037293054     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(02)00029-0     Document Type: Article

References (15)

1. Glover T.W., Berger C., Coyle J., Echo B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67:1984;136-142.
2. Sutherland G.R., Baker E., Richards R.I. Fragile sites still breaking. Trends Genet. 14:1998;501-506.
3. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
4. Huebner K., Croce C.M. FRA3B and other common fragile sites the weakest links . Nat. Rev. Cancer. 1:2001;214-221.
5. Jenkins R.B., et al. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res. 58:1998;759-766.
6. Huang H., et al. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Genes Chromosomes Cancer. 24:1999;48-55.
7. Zhang J.S., et al. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene. 17:1998;789-793.
8. J.A. Engelman, X.L. Zhang, M.P. Lisanti, Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers, FEBS Lett. 436 (1998) 403-410.
9. Tatarelli C., Linnenbach A., Mimori K., Croce C. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics. 68:2000;1-12.
10. Hayashi K., et al. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61:2001;2361-2364.
11. Wiechen K., et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:2001;1635-1643.
12. Ponzetto C., et al. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene. 6:1991;553-559.
13. Hellman A., et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell. 1:2002;89-97.
14. Ueda H.S., et al. Cell surface antigens of human renal cancer defined by autologous typing. J. Exp. Med. 150:1979;564-579.
15. Rege-Cambrin G., et al. Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. Cancer Genet. Cytogenet. 64:1992;170-173.